Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise Yardley, MD
Sarah Cannon Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rsm Durham Regional Cancer Center - Lakeridge Health
Oshawa, Ontario, Canada
- St. Joseph'S Health Centre
Toronto, Ontario, Canada
- Fakultni Nemocnice Olomouc
Olomouc, Czechia
- Radiologicke Centrum Multiscan, S.R.O.
Pardubice, Czechia
- Fakultani Nemocnice Kralavske Vinohadry
Praque, Czechia
- Allami Egeszseguegi Koezpont
Budapest, Hungary
- Semmelweis Egyetem
Budapest, Hungary
- Radiologicke Centrum Multiscan
Debrecen, Hungary
- Clinfan Ltd Smo, County Hospital Szekszard
Szekszárd, Hungary
- Arkhangelsk Regional Clinical Oncology Dispensary
Arkhangelsk, Russia
- Blokhin Russian Oncology Research Center of Russian Academy of Medical Sciences
Moscow, Russia
- Leningrad Regional Oncology Dispensary
Saint Petersburg, Russia
- Russian Research Centre of Radiology and Surgery
Saint Petersburg, Russia
- Stavropol Territory Clinical Oncology Dispensary
Stavropol, Russia
- California Cancer Care
Greenbrae, California, United States
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Scripps Health
La Jolla, California, United States
- University of Colorado
Aurora, Colorado, United States
- Rocky Mountain Cancer Center
Denver, Colorado, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Memorial Cancer Institute
Hollywood, Florida, United States
- University of Southern Florida -Moffitt Cancer Center
Tampa, Florida, United States
- Palm Beach Cancer Institute
West Palm Beach, Florida, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Indiana University Indiana Cancer Pavilion
Indianapolis, Indiana, United States
- University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
- Kansas City Cancer Center
Kansas City, Missouri, United States
- Hematology-Oncology Associates of Northern New Jersey
Morristown, New Jersey, United States
- Carolinas Healthcare System Clinical Trials
Charlotte, North Carolina, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States
- Sarah Cannon Cancer Center
Nashville, Tennessee, United States
- South Texas Cancer Center
McAllen, Texas, United States
- Virginia Cancer Institute
Richmond, Virginia, United States
- Columbia Basin Hematology & Oncology
Kennewick, Washington, United States
- Puget Sound Cancer Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jun 2008
- Primary completion
- 29 Jan 2011
- Completion
- 26 Nov 2012
- Last update posted
- 11 May 2022
- Registered enrollment
- 130
- Registry id
- NCT00676663
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.